Clinical Trials Directory

Trials / Unknown

UnknownNCT03955107

The Effect of Continuous Glucose Monitoring on Glycemic Control and Pregnancy Outcomes in Gestational Diabetes Mellitus

The Effect of Continuous Glucose Monitoring on Glycemic Control and Pregnancy Outcomes in Gestational Diabetes Mellitus:A Randomized Controlled Trial.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
154 (estimated)
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if Continuous glucose monitoring improves glycemic control and pregnancy outcomes of Gestational Diabetes Mellitus

Detailed description

Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance that is first identified during pregnancy, excluding diabetic patients diagnosed before pregnancy. The purpose of this study is to determine if Continuous glucose monitoring improves glycemic control and pregnancy outcomes of Gestational Diabetes Mellitus.

Conditions

Interventions

TypeNameDescription
DEVICEContinuous Glucose Monitoring SystemPatients in the intervention group will receive Continuous Glucose Monitoring(CGMS) every 4 weeks since diagnosed with GDM,and the control grouponly once receive CGMS during the last month and have management adjusted based on the CGMS readings Other Name: iPro, Medtronic

Timeline

Start date
2019-04-01
Primary completion
2020-03-01
Completion
2020-04-01
First posted
2019-05-17
Last updated
2019-05-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03955107. Inclusion in this directory is not an endorsement.